Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Medications

Low-dose combo antihypertensives effective for lowering BP

Low-dose combination (LDC) antihypertensives consisting of three or four blood pressure (BP)-lowering drugs are more effective for lowering BP compared with monotherapy, usual care, or placebo, according to a review published ...

page 1 from 5